Literature DB >> 29607127

Is the Sirolimus encapsulated balloon a reliable tool for treating the in-stent restenosis?-insights from the SABRE trial.

Daniele Andreini1,2, Daniela Trabattoni1.   

Abstract

Entities:  

Year:  2018        PMID： 29607127      PMCID： PMC5864652          DOI： 10.21037/jtd.2018.01.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

2.  Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.

Authors:  Mohammad Almalla; Jörg Schröder; Verena Pross; Nikolaus Marx; Rainer Hoffmann
Journal:  Catheter Cardiovasc Interv       Date:  2013-07-03       Impact factor: 2.692

3.  A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.

Authors:  Harald Rittger; Johannes Brachmann; Anil-M Sinha; Matthias Waliszewski; Marc Ohlow; Andreas Brugger; Holger Thiele; Ralf Birkemeyer; Volkhard Kurowski; Ole-A Breithardt; Martin Schmidt; Stefan Zimmermann; Sandra Lonke; Moritz von Cranach; The-Vinh Nguyen; Werner G Daniel; Jochen Wöhrle
Journal:  J Am Coll Cardiol       Date:  2012-02-29       Impact factor: 24.094

4.  A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.

Authors:  Seiji Habara; Masashi Iwabuchi; Naoto Inoue; Shigeru Nakamura; Ryuta Asano; Shinsuke Nanto; Yasuhiko Hayashi; Nobuo Shiode; Shigeru Saito; Yuji Ikari; Takeshi Kimura; Joji Hosokawa; Masato Nakamura; Jun-ichi Kotani; Ken Kozuma; Kazuaki Mitsudo
Journal:  Am Heart J       Date:  2013-08-13       Impact factor: 4.749

5.  A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).

Authors:  Fernando Alfonso; Maria Jose Pérez-Vizcayno; Alberto Cárdenas; Bruno García Del Blanco; Bernhard Seidelberger; Andrés Iñiguez; Manuel Gómez-Recio; Mónica Masotti; M Teresa Velázquez; Juan Sanchís; Arturo García-Touchard; Javier Zueco; Armando Bethencourt; Rafael Melgares; Angel Cequier; Antonio Dominguez; Vicente Mainar; José R López-Mínguez; José Moreu; Vicens Martí; Raúl Moreno; Pilar Jiménez-Quevedo; Nieves Gonzalo; Cristina Fernández; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2014-01-08       Impact factor: 24.094

Review 6.  In-stent restenosis in the drug-eluting stent era.

Authors:  George D Dangas; Bimmer E Claessen; Adriano Caixeta; Elias A Sanidas; Gary S Mintz; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

7.  A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.

Authors:  Bo Xu; Runlin Gao; Jian'an Wang; Yuejin Yang; Shaoliang Chen; Bin Liu; Fang Chen; Zhanquan Li; Yaling Han; Guosheng Fu; Yelin Zhao; Junbo Ge
Journal:  JACC Cardiovasc Interv       Date:  2014-02       Impact factor: 11.195

8.  Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model.

Authors:  Yvonne Patricia Clever; Daniel Peters; Jorge Calisse; Stephanie Bettink; Madeleine-Caroline Berg; Christian Sperling; Michael Stoever; Bodo Cremers; Bettina Kelsch; Michael Böhm; Ulrich Speck; Bruno Scheller
Journal:  Circ Cardiovasc Interv       Date:  2016-04       Impact factor: 6.546

9.  A comparison of bare-metal and drug-eluting stents for off-label indications.

Authors:  Oscar C Marroquin; Faith Selzer; Suresh R Mulukutla; David O Williams; Helen A Vlachos; Robert L Wilensky; Jean-François Tanguay; Elizabeth M Holper; J Dawn Abbott; Joon S Lee; Conrad Smith; William D Anderson; Sheryl F Kelsey; Kevin E Kip
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

10.  Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.

Authors:  Salvatore Cassese; Robert A Byrne; Tomohisa Tada; Susanne Pinieck; Michael Joner; Tareq Ibrahim; Lamin A King; Massimiliano Fusaro; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  Heart       Date:  2013-11-22       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.